Discovery could help develop a new treatment strategy for patients with melanoma

Source: News Medical Life Sciences, October 2021

A new study led by Yale Cancer Center researchers shows that the enzyme KDM5B suppresses anti-melanoma immunity. These findings could help develop a new treatment strategy to benefit patients with melanoma and other cancers, especially those who do not respond to current therapies. The research is published online today in the journal Nature.

READ THE ORIGINAL FULL ARTICLE
Menu